Document is current
Any future updates will be listed below
-
Authors
Xiao, Qin
Chu, Weifang
Guo, Jing
Gao, Jin
Yao, Wei
Huang, Minghuan
Lu, Yongzhou
Xu, Qiannan https://orcid.org/0000-0003-0707-7441
Xu, Nan
-
Funding
Funding for this research was provided by:
Central University Basic Research Fund of China (22120240377)
East Hospital Young Doctor Incubation Fund Project (YDNT-FP002)
Youth Research and Cultivation Fund of East Hospital (2023019)
National Natural Science Foundation of China (82202018)
Shanghai Pudong New Area Health Committee Supervision Institute (PWZzb2022-19)
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 24 September 2024
First Online: 8 October 2024
Declarations
:
: The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Human Ethics Committee of Shanghai East Hospital (Shanghai, China; Title of the approved project: Cytokine Change After CGF treatment; Approval No: 2022YS-238) on 2022.12.30. Written informed consent was obtained from individual or guardian participants. All experiments involving mice were approved by the Institutional Animal Care and Use Committee of Tongji University (Shanghai, China; Title of the approved project: Animal Experiment Approval “The effect of CGF microneedle injection on the imiquimod induced psoriatic mouse model”; Approval No: SYXK 2020-0002) on 2020.2.14.
: Not applicable.
: The authors declare that no conflicts of interest exist.
